Yew Bio-Pharm Group, Inc. Accumulated Other Comprehensive Income
Yew Bio-Pharm Group, Inc. had Accumulated Other Comprehensive Income of $1.12 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Accumulated Other Comprehensive Income (Loss), Net of Tax
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2021-11-15
- 2021-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.12M.
- 2021-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.08M.
- 2021-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $356.13K.
- 2020-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $608.24K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2021-09-30 | $1.12M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.08M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $356.13K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $608.24K 10-Q · filed 2021-11-15 |
| 2020-09-30 | -$1.23M 10-Q · filed 2020-11-13 |
| 2020-06-30 | -$2.90M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$3.01M 10-Q · filed 2020-06-29 |
| 2019-12-31 | -$2.19M 10-K · filed 2021-03-30 |
| 2018-12-31 | -$1.65M 10-K · filed 2020-05-14 |
| 2018-09-30 | -$1.76M 10-Q · filed 2018-11-19 |
| 2018-06-30 | -$137.38K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.26M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $706.63K 10-K · filed 2019-05-07 |
| 2017-09-30 | -$96.68K 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$887.23K 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$1.66M 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$1.97M 10-K · filed 2018-04-02 |
| 2015-12-31 | $665.68K 10-K · filed 2017-03-31 |